GENVEC (GNVC.O: Quote, Profile, Research), $0.89, up 11 pct

The company said FDA granted orphan drug status to its experimental pancreatic cancer treatment. [ID:nWNAB9831]

THOMAS PROPERTIES GROUP (TPGI.O: Quote, Profile, Research), $2.44, up 13 pct

The company postponed its previously announced public offering of 22 million shares of common stock citing unfavorable market conditions.

AMERICAN CAPITAL LTD (ACAS.O: Quote, Profile, Research), $2.88, up 6 pct

The struggling private-equity lender agreed with lenders to restructure its credit facility. [ID:nBNG414935] (Reporting by Jennifer Robin Raj in Bangalore)